Nexalin Technology (NXL) Short term Debt (2021)
Nexalin Technology (NXL) posted Short term Debt of $37200.0 for Q4 2021.
Powered by 
Analysis
Nexalin Technology (NXL) Short term Debt (2021) Analysis & Trends
Nexalin Technology has reported Short term Debt for 1 years, with the latest figure at $37200.0 in Q4 2021.
- On a quarterly basis, Short term Debt changed N/A year-over-year to $37200.0 in Q4 2021; TTM through Dec 2021 was $37200.0, a N/A change from a year earlier, with the FY2021 full-year figure at $37200.0, changed N/A from the prior year.
- Short term Debt was $37200.0 for Q4 2021 at Nexalin Technology.
- The five-year high for Short term Debt was $37200.0 in Q4 2021, with the low at $37200.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn |
| 3 | Medtronic | 117.17 Bn | 108.35 Bn | 6.34 Bn |
| 4 | Stryker | 104.15 Bn | 100.67 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.37 Bn | 62.83 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.75 Bn | 45.50 Bn | 1.35 Bn |
| 7 | Alcon | 33.01 Bn | 31.55 Bn | 1.68 Bn |
| 8 | Dexcom | 32.16 Bn | 30.22 Bn | 830.00 Mn |
| 9 | Steris | 20.74 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 3.42 Mn | 2.41 Mn | 8,897.00 |